The Hindu·4 min read·hard
Girl’s death in China reveals human cost of unregulated science
V
Vasudevan Mukunth
✦AI Summary
A six-year-old girl in China died following an experimental, unregulated gene-editing therapy aimed at treating a rare neurodevelopmental disorder. The case has sparked international debate regarding the ethics of high-risk medical interventions and the oversight of scientific research in China.
A six-year-old girl in China died in March 2025 after receiving what researchers said they believed was the world’s first base-editing therapy directed at the brain, according to an investigation by Science and Retraction Watch.
sciencehealthworld
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in